Answers are grounded in this paper and cite their sources.
The present study aimed to develop and statistically optimize immediate-release tablets of dapagliflozin using Response Surface Methodology (RSM) to achieve rapid drug release with acceptable tablet quality attributes. Immediate-release tablets of dapagliflozin were prepared by direct compression using varying concentrations of crosspovidone and starch. A three-level factorial design (32) was employed to optimize the formulation, where crosspovidone (X 1 ) and starch (X 2 ) served as independent variables, while hardness (Y 1 ), disintegration time (Y 2 ), and time required for 100% drug release (Y 3 ) were selected as dependent variables. Nine formulations were prepared and evaluated for pre- compression and post-compression characteristics, dissolution behavior, and release kinetics. All formulations complied with pharmacopoeial quality requirements. Statistical analysis demonstrated significant effects of crosspovidone and starch concentrations on tablet hardness, disintegration time, and drug release. The optimized formulation contained 22.0 mg of crosspovidone and 55.2 mg of starch, producing a hardness of 3.62 kg/cm 2 , a disintegration time of 49.7 s, and complete drug release within 26.6 min. Drug release followed zero-order kinetics and exhibited a Higuchi diffusion mechanism with non-Fickian release behavior. Response Surface Methodology successfully optimized the formulation of immediate- release dapagliflozin tablets. The optimized formulation exhibited desirable mechanical strength, rapid disintegration, and efficient drug release, demonstrating that RSM is an effective tool for the development and optimization of immediate-release tablet formulations.
No takes yet. Share an insight, caveat, or question.
Rao et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: